Delphi-Based Consensus on Treatment Intensification in Type 2 Diabetes Subjects Failing Basal Insulin Supported Oral Treatment: Focus on Basal Insulin + GLP-1 Receptor Agonist Combination Therapies-Reference-Cited by-同舟云学术

Delphi-Based Consensus on Treatment Intensification in Type 2 Diabetes Subjects Failing Basal Insulin Supported Oral Treatment: Focus on Basal Insulin + GLP-1 Receptor Agonist Combination Therapies

Published:2021-02-07 Issue:3 Volume:12 Page:781-800
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

Fadini Gian Paolo^ORCID,Disoteo Olga,Candido Riccardo,Di Bartolo Paolo,Laviola Luigi,Consoli Agostino

Funder

Ethos Srl

Novo Nordisk Fonden

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13300-021-01012-2.pdf

Reference56 articles.

1. Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2018;359(15):1577–89. https://doi.org/10.1056/NEJMoa0806470.

2. American Diabetes Association. 6. Glycemic targets: standards of medical care in diabetes—2020. Diabetes Care. 2020;43(Suppl 1):S66–76. https://doi.org/10.2337/dc20-S006.

3. Associazione Medici Diabetologi (AMD)–Società Italiana di Diabetologia (SID). Standard Italiani per la cura del diabete mellito 2018. (In Italian). https://aemmedi.it/wp-content/uploads/2009/06/AMD-Standard-unico1.pdf. Accessed 10 Nov 2020.

4. Davies MJ, D’Alessio DA, Fradkin J, et al. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018;41(12):2669–701. https://doi.org/10.2337/dci18-0033.

5. Associazione Medici Diabetologi (AMD). Avvio della terapia insulinica dal 2005 al 2011: Approcci prescrittivi e outcome dell’assistenza. (In Italian) https://aemmedi.it/files/ANNALI-AMD/2014/2014_Mono_terapia-insulinica_2005-2011.pdf. Accessed 10 Nov 2020.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toward Shared Decision-Making in Degenerative Cervical Myelopathy: Protocol for a Mixed Methods Study;JMIR Research Protocols;2023-10-09

2. Issues of insulin therapy for type 2 diabetes and ways to solve them;INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine);2023-06-01

3. Toward Shared Decision-Making in Degenerative Cervical Myelopathy: Protocol for a Mixed Methods Study (Preprint);2023-03-09

4. Switching to a fixed-ratio combination of insulin degludec/liraglutide (IDegLira) is associated with improved glycaemic control in a real-world population with type 2 diabetes mellitus in the United Arab Emirates: Results from the multicentre, prospective INTENSIFY study;Diabetes Research and Clinical Practice;2023-02

5. IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study;Diabetes Therapy;2022-06-18